A Review: The Pharmacology of Isoliquiritigenin

Phytotherapy Research

Volumn 29, Issue 7, 2015, Pages 969-977

  Peng, Fu ^a,b,c   Du, Qiaohui ^b,c   Peng, Cheng ^b,c   Wang, Neng ^a   Tang, Hailin ^a,d   Xie, Xiaoming ^d   Shen, Jiangang ^a   Chen, Jianping ^a,b,c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c State Key Laboratory Breeding Base of Systematic Research   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

isoliquiritigenin; natural medicine; pharmacological properties

Indexed keywords

2,4,4' DIACETOXY 2' HYDROXYCHALCONE; 3,2,4' DIMETHOXY 4 HYDROXYCHALCONE; 4 ACETOXY 2',4' DIMETHOXYCHALCONE; 5,4 BENZOYLOXY 2',4' DIMETHOXYCHALCONE; 6,2',4' DIMETHOXYCHALCONE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ISOLIQUIRITIGENIN; LIQUIRITIGENIN; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; CHALCONE DERIVATIVE; FLAVANONE DERIVATIVE; PLANT EXTRACT;

ADENOID CYSTIC CARCINOMA; ANOREXIA; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CHEMOPROPHYLAXIS; COLON CANCER; CORNEA NEOVASCULARIZATION; DIABETES MELLITUS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HUMAN; IMMUNOREGULATION; LEUKEMIA; LIVER CELL CARCINOMA; LIVER PROTECTION; LIVER TOXICITY; MOUTH CARCINOMA; MULTIPLE MYELOMA; NEUROPROTECTION; NONHUMAN; PROSTATE CANCER; UTERINE CERVIX CANCER; CHEMISTRY; GLYCYRRHIZA URALENSIS; PLANT ROOT;

GLYCYRRHIZA; GLYCYRRHIZA GLABRA; GLYCYRRHIZA URALENSIS;

CHALCONES; FLAVANONES; GLYCYRRHIZA URALENSIS; HUMANS; PLANT EXTRACTS; PLANT ROOTS;

EID: 84936866336     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5348     Document Type: Article

References (85)

1. Abdollahi M, Chan TS, Subrahmanyam V, O'Brien PJ,. 2003. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem 252: 205-211.
2. Arai T, Maejima Y, Muroya S, Yada T,. 2013. Rikkunshito and isoliquiritigenin counteract 5-HT-induced 2C receptor-mediated activation of pro-opiomelanocortin neurons in the hypothalamic arcuate nucleus. Neuropeptides 47: 225-230.
3. Asl MN, Hosseinzadeh H,. 2008. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22: 709-724.
4. Brown AK, Papaemmanouil A, Bhowruth V, Bhatt A, Dover LG, Besra GS,. 2007. Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology 153: 3314-3322.
5. Cao L, Liu H, Lam DS, Yam GH, Pang CP,. 2010. In vitro screening for angiostatic potential of herbal chemicals. Invest Ophthalmol Vis Sci 51: 6658-6664.
6. Chen H, Zhang B, Yuan X, et al., 2013. Isoliquiritigenin-induced effects on Nrf2 mediated antioxidant defence in the HL-60 cell monocytic differentiation. Cell Biol Int 37: 1215-1224.
7. Chen H, Zhang B, Yao Y, et al., 2012a. NADPH oxidase-derived reactive oxygen species are involved in the HL-60 cell monocytic differentiation induced by isoliquiritigenin. Molecules 117: 13424-13438.
8. Chen X, Wu Y, Jiang Y, et al., 2012b. Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. J Mol Med 90: 1311-1319.
9. Chen X, Zhang B, Yuan X, et al., 2012c. Isoliquiritigenin-induced differentiation in mouse melanoma B16F0 cell line Hindawi Publishing Corporation. Oxid Med Cell Longev 2012. doi: 10.1155/2012/534934.
10. Chin YW, Jung HA, Liu Y, et al., 2007. Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem 55: 4691-4697.
11. Chowdhury SA, Kishino K, Satoh R, et al., 2005. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25: 2055-2063.
12. Cuendet M, Guo J, Luo Y, et al., 2010. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. Cancer Prev Res (Phila) 3: 221-232.
13. Cuendet M, Oteham CP, Moon RC, Pezzuto JM,. 2006. Quinone reductase induction as a biomarker for cancer chemoprevention. J Nat Prod 69: 460-463.
14. De Bartolo L, Morelli S, Gallo MC, et al., 2005. Effect of isoliquiritigenin on viability and differentiated functions of human hepatocytes maintained on PEEK-WC-polyurethane membranes. Biomaterials 26: 6625-6634.
15. Feldman M, Santos J, Grenier D,. 2011. Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential 1. J Nat Prod 74: 1862-1867.
16. Gaur R, Kumar S, Trivedi P, et al., 2010. Liquiritigenin derivatives and their hepatoprotective activity. Nat Prod Commun 5: 1243-1246.
17. Gaur R, Yadav KS, Verma RK, Yadav NP, Bhakuni RS,. 2014. In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine 21: 415-422.
18. Hattori T, Sadakane C, Koseki J, Kase Y, Takeda S,. 2007. Saireito probably prevents mesangial cell proliferation in HIGA mice via PDGF-BB tyrosine kinase inhibition. Clin Exp Nephrol 11: 275-282.
19. Hirchaud F, et al., 2013. Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca ski cells. Planta Med 79: 1628-1635.
20. Hsu YL, Kuo PL, Chiang LC, Lin CC,. 2004. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. Clin Exp Pharmacol Physiol 31: 414-418.
21. Hsu YL, Kuo PL, Lin CC,. 2005a. Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells. Life Sci 77: 279-292.
22. Hsu YL, Kuo PL, Lin LT, Lin CC,. 2005b. Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med 71: 130-134.
23. CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 207: 27-35.
24. Jang EY, Choe ES, Hwang M, et al., 2008. Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABAB receptor. Eur J Pharmacol 587: 124-128.
25. Jang DS, Park EJ, Hawthorne ME, et al., 2003. Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (Tonka bean). J Nat Prod 66: 583-587.
26. Jhanji V, Liu H, Law K, et al., 2011. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. Br J Ophthalmol 95: 1309-1315.
27. Jung JI, Chung E, Seon MR, et al., 2006a. Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 28: 159-168.
28. Jung JI, Lim SS, Choi HJ, et al., 2006b. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 17: 689-696.
29. Kanazawa M, Satomi Y, Mizutani Y, et al., 2003. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 43: 580-586.
30. Kang SW, Choi JS, Choi YJ, et al., 2010. Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. J Nutr Biochem 21: 55-65.
31. Kim DC, et al., 2008. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod Sci 15: 552-558.
32. Kim DC, Choi SY, Kim SH, et al., 2006. Isoliquiritigenin selectively inhibits H2 histamine receptor signaling. Mol Pharmacol 70: 493-500.
33. Kim YM, Kim TH, Kim YW, et al., 2010. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition. Free Radic Biol Med 49: 1722-1734.
34. Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH,. 2009. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 20: 663-676.
35. Kwon HM, Choi YJ, Choi JS, et al., 2007. Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappa B signal disruption. Exp Biol Med (Maywood) 232: 235-245.
36. Lau GT, Ye L, Leung LK,. 2010. The licorice flavonoid isoliquiritigenin suppresses phorbol ester-induced cyclooxygenase-2 expression in the non-tumorigenic MCF-10A breast cell line. Planta Med 76: 780-785.
37. Lee HK, Yang EJ, Kim JY, Song KS, Seong YH,. 2012. Inhibitory effects of Glycyrrhizae radix and its active component, isoliquiritigenin, on Aβ(25-35)-induced neurotoxicity in cultured rat cortical neurons. Arch Pharm Res 35: 897-904.
38. Lee MJ, Yang CH, Jeon JP, Hwang M,. 2009a. Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice. J Pharmacol Sci 2: 216-220.
39. Lee SK, Park KK, Park JH, Lim SS, Chung WY,. 2013. The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction. Phytother Res 27: 1776-1783.
40. Lee SH, Kim JY, Seo GS, Kim YC, Sohn DH,. 2009b. Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages. Inflamm Res 58: 257-262.
41. Lee SH, Kim SH, Jung SH, Kim JK, Pan CH, Lim SS,. 2010a. Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Biol Pharm Bull 33: 917-921.
42. Lee YM, Lim do Y, Choi HJ, Jung JI, Chung WY, Park JH,. 2009c. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin. J Med Food 12: 8-14.
43. Lee YM, Jeong GS, Lim HD, An RB, Kim YC, Kim EC,. 2010b. Isoliquiritigenin 20-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol In Vitro 24: 776-782.
44. Li D, et al., 2009a. Isoliquiritigenin induces monocytic differentiation of HL-60 cells. Free Radic Biol Med 46: 731-736.
45. Li J, Kang SW, Kim JL, Sung HY, Kwun IS, Kang YH,. 2010a. Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation. J Agric Food Chem 58: 3205-3212.
46. Li W, Sun YN, Yan XT, et al., 2014. Flavonoids from Astragalus membranaceus and their inhibitory effects on LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells. Arch Pharm Res 37: 186-192.
47. Li S, Li W, Wang Y, Asada Y, Koike K,. 2010b. Prenylflavonoids from Glycyrrhiza uralensis and their protein tyrosine phosphatase-1B inhibitory activities. Bioorg Med Chem Lett 20: 5398-5401.
48. Li X, Xue X, Li PC,. 2009b. Real-time detection of the early event of cytotoxicity of herbal ingredients on single leukemia cells studied in a microfluidic biochip. Integr Biol 1: 90-98.
49. Li Y, Zhao H, Wang Y, et al., 2013. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol 272: 37-48.
50. Lorusso V, Marech I,. 2013. Novel plant-derived target drugs: a step forward from licorice? Expert Opin Ther Targets 17: 333-335.
51. Muanprasat C, Sirianant L, Soodvilai S, Chokchaisiri R, Suksamrarn A, Chatsudthipong V,. 2012. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease. J Pharmacol Sci 118: 82-91.
52. Nerya O, Vaya J, Musa R, Izrael S, Ben-Arie R, Tamir S,. 2003. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J Agric Food Chem 51: 1201-1207.
53. Noguchi C, Yang J, Sakamoto K, et al., 2008. Inhibitory effects of isoliquiritigenin and licorice extract on voltage-dependent K+ currents in H9c2 cells. J Pharmacol Sci 108: 439-445.
54. Ohno H, et al., 2013. Evaluation of cytotoxicity and tumor-specificity of licorice flavonoids based on chemical structure. Anticancer Res 33: 3061-3068.
55. Park I, Park KK, Park JH, Chung WY,. 2009a. Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition. Cancer Lett 277: 174-181.
56. Park SJ, Song HY, Youn HS,. 2009b. Suppression of the TRIF-dependent signaling pathway of toll-like receptors by isoliquiritigenin in RAW264.7 macrophages. Mol Cells 28: 365-368.
57. Park SJ, Youn HS,. 2010a. Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry 71: 1736-1740.
58. Park SJ, Youn HS,. 2010b. Isoliquiritigenin suppresses the toll-interleukin-1 receptor domain-containing adapter inducing interferon-beta (TRIF)-dependent signaling pathway of toll-like receptors by targeting TBK1. J Agric Food Chem 58: 4701-4705.
59. Ryu YB, Kim JH, Park SJ, et al., 2010. Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg Med Chem Lett 20: 971-974.
60. Shi Y, et al., 2012. Analgesic and uterine relaxant effects of isoliquiritigenin, a flavone from Glycyrrhiza glabra. Phytother Res 26: 1410-1417.
61. Sun C, Zhang H, Ma XF, et al., 2013. Isoliquiritigenin enhances radio sensitivity of HepG2 cells via disturbance of redox status. Cell Biochem Biophys 65: 433-444.
62. Sun ZJ, Chen G, Zhang W, et al., 2010. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase. J Pharmacol Exp Ther 334: 500-512.
63. Takeda H, Muto S, Hattori T, et al., 2010. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 151: 244-252.
64. Takahashia T, Baba M, Nishino H, Okuyama T,. 2006. Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells. Cancer Lett 231: 319-325.
65. Takahashi T, Takasuka N, Iigo M, et al., 2004. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95: 448-453.
66. Wang Z, Wang N, Han S, et al., 2013. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One 8: e68566.
67. Wei AN, J Y, Ao Y,. 2006. Metallothionein mediates cardio protection of isoliquiritigenin against ischemia-reperfusion through JAK2/STAT3 activation. Acta Pharmacol Sin 27: 1431-1437.
68. Woo SW, Lee SH, Ko G, Kim YC, Sohn DH,. 2008. Isoliquiritigenin inhibits cell proliferation by a heme oxygenase-dependent pathway in rat hepatic stellate cells. Planta Med 74: 834-839.
69. Wu CP, Ohnuma S, Ambudkar SV,. 2011. Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy. Curr Pharm Biotechnol 12: 609-620.
70. Yamada C, Saegusa Y, Nakagawa K, et al., 2013. A Japanese kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model. Biomed Res Int 2013. doi: 10.1155/2013/792940.
71. Yang EJ, Min JS, Ku HY, et al., 2012. Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. Biochem Biophys Res Commun 421: 658-664.
72. Yang N, Patil S, Zhuge J, et al., 2013. Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMITM, inhibit memory Th2 responses in vitro and in vivo. Phytother Res 27: 1381-1391.
73. Yoshida T, Horinaka M, Takara M, et al., 2008. Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells. Environ Health Prev Med 13: 281-287.
74. Yuan X, Yu B, Wang Y, et al., 2013a. Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis. Recent Pat Anticancer Drug Discov 8: 191-199.
75. Yuan X, Zhang B, Chen N, et al., 2012. Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells. J Asian Nat Prod Res 8: 789-798.
76. Yuan X, Zhang B, Gan L, et al., 2013b. Involvement of the mitochondrion-dependent and the endoplasmic reticulum stress-signaling pathways in isoliquiritigenin-induced apoptosis of HeLa cell. Biomed Environ Sci 26: 268-276.
77. Zhan C, Yang J,. 2006. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 53: 303-309.
78. Zhang XY, Qiao H, Ni JM, Shi YB, Qiang Y,. 2013a. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. Eur J Pharm Sci 49: 411-422.
79. Zhang X, Yeung ED, Wang J, et al., 2010. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. Clin Exp Pharmacol Physiol 37: 841-847.
80. Zhang X, Zhu P, Zhang X, et al., 2013b. Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway. Mediators Inflamm 2013: 390890.
81. Zhang SW, Zhou SY, Shao JC, Qu XW,. 2009. Primary research on Chinese medicine treatment of androgen-independent prostate cancer. Chin J Integr Med 15: 168-169.
82. Zhao H, Yuan X, Li D, et al., 2013. Isoliquiritigenin enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide. Molecules 18: 8786-8798.
83. Zhao X, Mei W, Gong M, Zuo W, Bai H, Dai H,. 2011. Antibacterial activity of the flavonoids from Dalbergia odorifera on Ralstonia solanacearum. Molecules 16: 9775-9782.
84. Zhou GS, Song LJ, Yang B,. 2013. Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro. Mol Med Rep 7: 531-536.
85. Zu Y, Liu X, Fu Y, et al., 2009. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage. Planta Med 75: 1134-1140.